Unless you’ve been on vacation in the Amazon, you’ve heard the reports: AstraZeneca CEO Pascal Soriot was said to have signed on as the new chief at Teva. Friday, though, AZ said Soriot would be around to lead its July 27 earnings call. It appeared to be a nonconfirmation confirmation that he’s staying put. We have some theories.
More: What really happened with Pascal Soriot's rumored move to Teva?